SUBJECTS : Drug Discovery | Drug Delivery | Medicinal Chemistry | | Translational Science | Cell Therap
Medicine in Drug Discovery: 2020, vol: , issue:
- 1)- Di Liu, Qiang Wang, Huacai Zhang, Li Cui, Feng Shen, Yong Chen, Jiali Sun, Lebin Gan, Jianhui Sun, Jun Wang, Jing Zhang, Qingli Cai, Jin Deng, Jianxin Jiang, Ling Zeng. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19). Medicine in drug discovery. 2020, 8: 100057
Cited : 35Read More - 2)- Hanxiao Yu, He Yang, Enxue Shi, Wenjun Tang. Development and Clinical Application of Phosphorus-Containing Drugs. Medicine in drug discovery. 2020, 8: 100063Cited : 109Read More
- 3)- Cristian Arvinte, Maharaj Singh, Paul E Marik. Serum Levels of Vitamin C and Vitamin D in a Cohort of Critically Ill COVID-19 Patients of a North American Community Hospital Intensive Care Unit in May 2020: A Pilot Study. Medicine in drug discovery. 2020, 8: 100064Cited : 91Read More
- 4)- Karli Montague-Cardoso, Marzia Malcangio. Cathepsin S as a potential therapeutic target for chronic pain. Medicine in drug discovery. 2020, 7: 100047Cited : 10Read More
- 5)- Mingyan Deng, Ling Jiang, Yan Ren, Jiayu Liao. Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control? Medicine in drug discovery. 2020, 7: 100048Cited : 3Read More
- 6)- Keshav Rajarshi, Aroni Chatterjee, Shashikant Ray. BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope? Medicine in drug discovery. 2020, 7: 100049Cited : 15Read More
- 7)- Karan Razdan, Kuldeep Singh, Dilpreet Singh. Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? Medicine in drug discovery. 2020, 7: 100051Cited : 52Read More
- 8)- B Solun, Y Shoenfeld. Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19. Medicine in drug discovery. 2020, 7: 100052Cited : 51Read More
- 9)- Chenglong Liu, Albrecht von Brunn, Di Zhu. Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19. Medicine in drug discovery. 2020, 7: 100056Cited : 69Read More
- 10)- Shurong Zhou, Wenjie Chen, Janet Cole, Guizhi Zhu. Delivery of nucleic acid therapeutics for cancer immunotherapy. Medicine in drug discovery. 2020, 6: Cited : 23Read More
- 11)- Mohammad A Uddin, Khadeja-Tul Kubra, Jafrin Jobayer Sonju, Mohammad S Akhter, Jois Seetharama, Nektarios Barabutis. Effects of Heat Shock Protein 90 Inhibition In the Lungs. Medicine in drug discovery. 2020, 6: Cited : 23Read More
- 12)- Kim D Janda, Michael J Iadarola. Standing out from the crowd in treating COVID-19. Medicine in drug discovery. 2020, 6: 100034Cited : 2Read More
- 13)- Hiroshi Maruta, Hong He. PAK1-blockers: Potential Therapeutics against COVID-19. Medicine in drug discovery. 2020, 6: 100039Cited : 77Read More
- 14)- Paul E Marik, Pierre Kory, Joseph Varon. Does vitamin D status impact mortality from SARS-CoV-2 infection? Medicine in drug discovery. 2020, 6: 100041Cited : 90Read More
- 15)- Mahesh Kandasamy. Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19. Medicine in drug discovery. 2020, 6: 100042Cited : 20Read More
- 16)- Russel J Reiter, Ramaswamy Sharma, Qiang Ma, Alberto Dominquez-Rodriguez, Paul E Marik, Pedro Abreu-Gonzalez. Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis. Medicine in drug discovery. 2020, 6: 100044Cited : 56Read More
- 17)- Su M Metcalfe. Mesenchymal stem cells and management of COVID-19 pneumonia. Medicine in drug discovery. 2020, 5: 100019Cited : 111Read More
- 18)- Henry Ji, Ying Yan, Beibei Ding, Wenzhong Guo, Mark Brunswick, Andreas Niethammer, Williams SooHoo, Robin Smith, Alexis Nahama, Yanliang Zhang. Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus. Medicine in drug discovery. 2020, 5: 100026Cited : 14Read More
- 19)- Richard Z Cheng. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Medicine in drug discovery. 2020, 5: 100028Cited : 144Read More
- 20)- Alexis Nahama, Roshni Ramachandran, Alvaro Francisco Cisternas, Henry Ji. The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A review. Medicine in drug discovery. 2020, 5: 100033Cited : 29Read More
- 21)- Tony Y Zhang, Boyu Zhong. Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19. Medicine in drug discovery. 2020, 5: 100036Cited : 14Read More
- 22)- Jiayu Liao, George Way, Vipul Madahar. Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenza virus therapies. Medicine in drug discovery. 2020, 5: 100037Cited : 11Read More
- 23)- Ernesto Estrada. Protein-driven mechanism of multiorgan damage in COVID-19. Medicine in drug discovery. 2020, : 100069Cited : 7Read More
